Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 201–300 of 2,013
Pateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 156
“However, the control of SIR by persistent DDR and the sequence of events in relation with SASP remain elusive.”
BackgroundInfluentialAge-Related Impairment of Pancreatic Beta-Cell Function: Pathophysiological and Cellular Mechanisms
Tata, V. D. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00138 · Cited by 171
“Cellular senescence was firstly described more than 50 years ago by Hayflick and Moorhead (91) as a process limiting the proliferation of normal human fibroblasts in culture, and this term is now generally used to indicate the essentially irreversible growth arrest that occurs when cells that can divide are challenged…”
BackgroundStromal-Initiated Changes in the Bone Promote Metastatic Niche Development
Luo, X., Fu, Y., Loza, A. J., Murali, B., Leahy, K. M., Ruhland, M. K., Gang, M., Su, X., Zamani, A., Shi, Y., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.016 · Cited by 141
“While each of these categories is expressed in cells undergoing senescence, the exact factors vary depending on the cell of origin and the tissue under scrutiny (Coppé et al., 2008; Kuilman et al., 2008; Rodier and Campisi, 2011; Ruhland et al., 2015).”
SIRT4 interacts with OPA1 and regulates mitochondrial quality control and mitophagy
Lang, A., Anand, R., Altinoluk-Hambüchen, S., Ezzahoini, H., Stefanski, A., Iram, A., Bergmann, L., Urbach, J., Böhler, P., Hänsel, J., et al. (2017) · Aging · doi:10.18632/aging.101307 · Cited by 147
Cellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44/42MAPK Signaling
Alimirah, F., Pulido, T., Valdovinos, A., Alptekin, S., Chang, E., Jones, E., Diaz, D. A., Flores, J., Velarde, M. C., Demaria, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0108 · Cited by 128
“This response is often triggered by potentially oncogenic stressors, and thus prevents stressed cells fromprogressing through the cell cycle and ultimately to malignancy (1).”
BackgroundInfluentialSelf-citationTăcutu, R., Budovsky, A., Yanai, H., & Fraifeld, V. E. (2011) · Aging · doi:10.18632/aging.100413 · Cited by 150
“focus on the interplay between their components [11, 12, 20, 21].”
BackgroundFoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence
Macedo, J. C., Vaz, S., Bakker, B., Ribeiro, R., Bakker, P. L., Escandell, J. M., Ferreira, M. G., Medema, R., Foijer, F., & Logarinho, E. (2018) · Nature Communications · doi:10.1038/s41467-018-05258-6 · Cited by 131
MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways
Hu, Z., Klein, J. D., Mitch, W. E., Zhang, L., Martinez, I., & Wang, X. H. (2014) · Aging · doi:10.18632/aging.100643 · Cited by 140
“This response can impact tumor suppression (growth arrest in early life) and tumor promotion (chronic inflammatory response in late life) [7].”
BackgroundThe Role of Curcumin in the Modulation of Ageing
Bielak-Żmijewska, A., Grabowska, W., Ciolko, A., Bojko, A., Mosieniak, G., Bijoch, Ł., & Sikora, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051239 · Cited by 150
“It seems that senescent cells are very well characterized and relatively easy to distinguish from non-senescent cells [18].”
BackgroundGuo, Y., Ayers, J. L., Carter, K. T., Wang, T., Maden, S. K., Edmond, D., Newcomb P, P., Li, C., Ulrich, C., Yu, M., et al. (2019) · Aging Cell · doi:10.1111/acel.13013 · Cited by 139
“Cellular senescence is an irreversible growth arrest that occurs in response to a variety of different stimuli, including oxidative stress, radia‐ tion, and oncogenic stress (Rodier & Campisi, 2011).”
BackgroundRole of the inflammation-autophagy-senescence integrative network in osteoarthritis
Vinatier, C., Domínguez, E., Guicheux, J., & Caramés, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00706 · Cited by 135
“SASP is thus seen as a driver of age-related inflammation, at least under certain conditions (Rodier and Campisi, 2011).”
BackgroundInfluentialConsensus nomenclature for CD8+T cell phenotypes in cancer
Apétoh, L., Smyth, M. J., Drake, C. G., Abastado, J., Apte, R. N., Ayyoub, M., Blay, J., Bonneville, M., Butterfield, L. H., Caignard, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.998538 · Cited by 157
Lang, A., Grether‐Beck, S., Singh, M., Kuck, F., Jakob, S., Kefalas, A., Altinoluk-Hambüchen, S., Graffmann, N., Schneider, M., Lindecke, A., et al. (2016) · Aging · doi:10.18632/aging.100905 · Cited by 146
Oxidative Stress Induces Telomere Dysfunction and Senescence by Replication Fork Arrest
Coluzzi, E., Leone, S., & Sgura, A. (2019) · Cells · doi:10.3390/cells8010019 · Cited by 138
Colorimetric Detection of Senescence-Associated β Galactosidase
Itahana, K., Itahana, Y., & Dimri, G. P. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_8 · Cited by 164
“Several laboratories have recently shown that senescent cells also secrete many kinds of growth factors, proteases, and cytokines that can promote cancer progression and aging to cause detrimental effects (27), suggesting very complex roles for senescent cells in vivo (2).”
Ling, P., Lei, J., Jia, L., & Ju, H. (2015) · Chemical Communications · doi:10.1039/c5cc08418k · Cited by 137
Burova, E., Borodkina, A. V., Shatrova, A. N., & Nikolsky, N. N. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/474931 · Cited by 134
“Senescence program seems to develop in mesenchymal stem cells as a result of DNA damage response, leading to functional activation of either the p53/p21 or the p16INK4a (p16)/retinoblastoma protein (pRb) pathway, both of which can establish and maintain the growth arrest that is typical of senescence [23, 24].”
BackgroundCancer and Aging - the Inflammatory Connection
Zinger, A., Cho, W. C. S., & Ben‐Yehuda, A. (2017) · Aging and Disease · doi:10.14336/ad.2016.1230 · Cited by 154
“Chronic inflammation contributes to initiation and / or propagation of multiple pathologic processes, including degenerative disorders that accompany aging, and hyperplastic disorders including cancer [6, 95-97].”
BackgroundA Mouse Model of Accelerated Liver Aging Caused by a Defect in DNA Repair
Gregg, S. Q., Gutiérrez, V., Robinson, A. R., Woodell, T. B., Nakao, A., Ross, M. A., Michalopoulos, G. K., Rigatti, L. H., Rothermel, C. E., Kamileri, I., et al. (2011) · Hepatology · doi:10.1002/hep.24713 · Cited by 156
Senescent glia link mitochondrial dysfunction and lipid accumulation
Byrns, C. N., Perlegos, A. E., Miller, K. N., Jin, Z., Carranza, F. R., Manchandra, P., Beveridge, C. H., Randolph, C. E., Chaluvadi, V. S., Zhang, S. L., et al. (2024) · Nature · doi:10.1038/s41586-024-07516-8 · Cited by 136
The Janus Head of T Cell Aging – Autoimmunity and Immunodeficiency
Goronzy, J. J., Li, G., Yang, Z., & Weyand, C. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00131 · Cited by 134
“Rodier and Campisi (2011) have described the senescenceassociated secretory phenotype (SASP) in senescent fibroblasts which may be applicable to other cell types as well.”
BackgroundCui, Y., & Guo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111942 · Cited by 133
“Additionally, senescent cells with highly activated p53 pathway secrete numerous inflammatory cytokines, chemokines, growth factors, and other soluble proteins via activating the NF-κB pathway [91,92].”
BackgroundCancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Maleki, E. H., Bahrami, A. R., & Matin, M. M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.11.025 · Cited by 145
“Besides, these cells express some markers such as senescence-associated heterochromatin foci (SAHF), senescence-associated b-galactosidase and nuclear foci containing DNA damage proteins (DNA-SCARS), which are not found in quiescent cells.(78) Furthermore, some reports that characterize senescence involve prolonged ar…”
BackgroundCellular senescence links aging and diabetes in cardiovascular disease
Shakeri, H., Lemmens, K., Gevaert, A. B., De Meyer, G. R. Y., & Segers, V. F. M. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00287.2018 · Cited by 134
“Cellular senescence is a fundamental feature of aging, but it was originally described as an important mechanism that prevents tumorigenesis by limiting proliferation of potential cancer cells (21, 158).”
BackgroundSécher, T., Samba‐Louaka, A., Oswald, É., & Nougayrède, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077157 · Cited by 156
“Nevertheless, only a limited number of studies highlights a role of bacterial products in the induction of cellular senescence while the role of senescence in the host-repair response to infection/inflammation is beginning to emerge [4].”
Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 132
“In mammalian cells, the retinoblastoma (RB) family of pocket proteins and the tumor suppressor p53 play a key role in the senescent cell-cycle inhibition [31].”
BackgroundHEI-OC1 cells as a model for investigating drug cytotoxicity
Kalinec, G. M., Thein, P., Park, C., & Kalinec, F. (2016) · Hearing Research · doi:10.1016/j.heares.2016.02.019 · Cited by 141
“Recently, it has become apparent that cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression (Rodier and Campisi, 2011).”
Calcium signaling and cellular senescence
Martin, N., & Bernard, D. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.04.001 · Cited by 138
Santoro, A., Pini, E., Scurti, M., Palmas, M. G., Berendsen, A. A. M., Brzozowska, A., Pietruszka, B., Szczecińska, A., Cano, N., Meunier, N., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.12.001 · Cited by 144
“Senescent cells are in fact characterized by the capability to produce high amounts of proinflammatory proteins (Rodier and Campisi, 2011; Olivieri et al., 2012a).”
Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells
Zuellig, R. A., Hornemann, T., Othman, A., Hehl, A. B., Bode, H., Güntert, T., Ogunshola, O. O., Saponara, E., Grabliauskaite, K., Jang, J., et al. (2013) · Diabetes · doi:10.2337/db13-1042 · Cited by 139
“2B and C), a hallmark (16) and inducer of senescence (17), respectively.”
BackgroundFlavonoids in Skin Senescence Prevention and Treatment
Domaszewska-Szostek, A., Puzianowska-Kuźnicka, M., & Kuryłowicz, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136814 · Cited by 130
“Thus, there is an increasing need to understand the mechanisms underlying this highly complex process [1], which inevitably leads to impaired body homeostasis and function, an increased risk of complex diseases, and, finally, death.”
BackgroundNatural compounds with anti-ageing activity
Argyropoulou, A., Aligiannis, N., Trougakos, I. P., & Skaltsounis, A. (2013) · Natural Product Reports · doi:10.1039/c3np70031c · Cited by 135
Telomere dysfunction, autoimmunity and aging.
(2011) · Europe PMC (PubMed Central) · Cited by 138
Therapy-Induced Senescence Drives Bone Loss
Yao, Z., Murali, B., Ren, Q., Luo, X., Faget, D. V., Cole, T., Ricci, B., Thotala, D., Monahan, J., van Deursen, J. M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2348 · Cited by 129
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 140
“In fact, senescence may be seen as a cancer suppressor mechanism, with the inflammatory SASP phenotype inducing immune cells to modulate tissue regeneration and senescent cell removal, and secreting pro-senescent, pro-apoptotic and anti-angiogenic factors (reviewed by [69]).”
BackgroundLesina, M., Wörmann, S. M., Morton, J., Diakopoulos, K. N., Korneeva, O., Wimmer, M., Einwächter, H., Sperveslage, J., Demir, I. E., Kehl, T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86477 · Cited by 128
“OIS is a failsafe mechanism that prevents the development of cancer in precancerous lesions of various tumors, including PDAC (29).”
BackgroundFOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
Khongkow, P., Karunarathna, U., Khongkow, M., Gong, C., Gomes, A., Yagüe, E., Monteiro, L. J., Kongsema, M., Zona, S., Man, E. P. S., et al. (2013) · Oncogene · doi:10.1038/onc.2013.457 · Cited by 132
“Cells can be induced to undergo premature senescence by intracellular as well as extracellular stress including irradiation, persistent DNA damage response, oncogene activation, telomere erosion, oxidative stress, toxins and stem cell reprogramming (13).”
BackgroundMaciel-Barón, L. A., Morales-Rosales, S. L., Aquino-Cruz, A. A., Triana-Martínez, F., Galván-Arzate, S., Luna-López, A., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., & Königsberg, M. (2016) · AGE · doi:10.1007/s11357-016-9886-1 · Cited by 128
“Cellular senescence is an intricate and multifactorial phenomenon of growth arrest and distorted function (Vijg and Campisi 2008), which has been recognized as an important feature during tumor suppression and a contributor to aging (Rodier and Campisi 2011).”
BackgroundInfluentialEndothelial Function and Dysfunction: Impact of Metformin
Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128
Kumar, M., Seeger, W., & Voswinckel, R. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0382ps · Cited by 136
“The physiological role of SASP has been proposed to be a wound healing mechanism (47).”
BackgroundThe DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
“Cellular senescence is typically defined as a state of irreversible cell-cycle arrest that is characterized by changes in gene expression, and morphological and phenotypic alterations to organelle and macro cell structures [163].”
Cell Autonomous and non-autonomous effects of senescent cells in the skin
Demaria, M., Desprez, P. Y., Campisi, J., & Velarde, M. C. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.108 · Cited by 127
“As part of the senescence response, senescent cells express a number of non-exclusive markers, including the cell cycle inhibitor p16 and elevated levels of a lysosomal enzyme, termed as senescence-associated β-galactosidase (Rodier and Campisi, 2011).”
BackgroundCaveolin‐1, cancer and therapy resistance
Ketteler, J., & Klein, D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31369 · Cited by 135
Evangelou, K., & Gorgoulis, V. G. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6670-7_10 · Cited by 124
mTOR Signaling from Cellular Senescence to Organismal Aging
Xu, S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500263 · Cited by 139
“Such ideas find plenty of experimental supports in the literature [81].”
Wang, Z., Ma, L., Su, M., Zhou, Y., Mao, K., Li, C., Peng, G., Zhou, C., Shen, B., & Dou, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0223-0 · Cited by 126
de Mera‐Rodríguez, J. A., Álvarez‐Hernán, G., Gañán, Y., Martín‐Partido, G., Rodríguez‐León, J., & Francisco‐Morcillo, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.623175 · Cited by 144
“Cellular senescence is characterized by a prolonged and irreversible cell-cycle arrest with secretory features, macromolecular damage, and altered metabolism (Campisi et al., 2011; Rodier and Campisi, 2011; Childs et al., 2015; Hernandez-Segura et al., 2018; Gorgoulis et al., 2019).”
BackgroundNassour, J., Martien, S., Martin, N., Deruy, E., Tomellini, E., Malaquin, N., Bouali, F., Sabatier, L., Wernert, N., Pinte, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10399 · Cited by 137
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Kolesnichenko, M., Hong, L., Liao, R., Vogt, P. K., & Sun, P. (2012) · Cell Cycle · doi:10.4161/cc.20683 · Cited by 123
“These have as their common endpoint the cessation of cell proliferation tied to characteristic changes in cellular morphology, increase in lysosomal mass, secretion of inflammatory cytokines and increased expression of pro-senescence proteins.(2-5) This report addresses two well-characterized types of senescence: RAS-…”
BackgroundInfluentialDNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.008 · Cited by 122
“Replicative cellular senescence is believed to be an important mechanism for suppressing tumorigenesis (Campisi, 2001; Kuilman et al., 2010; Michaloglou et al., 2005; Rodier and Campisi, 2011).”
Aging-dependent regulatory cells emerge in subcutaneous fat to inhibit adipogenesis
Nguyen, H. P., Lin, F., Yi, D., Xie, Y., Dinh, J., Xue, P., & Sul, H. S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.03.026 · Cited by 129
MicroRNA Regulation of Oxidative Stress‐Induced Cellular Senescence
Bu, H., Wedel, S., Cavinato, M., & Jansen-Dürr, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2398696 · Cited by 122
“ROS causes senescence associated cell-cycle arrest by triggering DDR pathway to stabilize p53 and transactivate p21 gene expression [19].”
BackgroundInfluentialAlessio, N., Gaudio, S. D., Capasso, S., Bernardo, G. D., Cappabianca, S., Cipollaro, M., Peluso, G., & Galderisi, U. (2014) · Oncotarget · doi:10.18632/oncotarget.2692 · Cited by 137
“The existence of persistent unrepaired DNA foci may be the trigger of senescence phenomena as already evidenced by Campisi’s team, who showed that persistent foci of damaged DNA, termed DNA-SCARS, sustain damage-induced senescence growth arrest [44].”
BackgroundMDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
Vilgelm, A. E., Saleh, N., Shattuck-Brandt, R., Riemenschneider, K., Slesur, L., Chen, S.-C., Johnson, C. A., Yang, J., Blevins, A., Yan, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav7171 · Cited by 122
“Similar expression changes have been reported in cells undergoing senescence (43).”
BackgroundCellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 135
Age-related changes in the knee meniscus
Tsujii, A., Nakamura, N., & Horibe, S. (2017) · The Knee · doi:10.1016/j.knee.2017.08.001 · Cited by 131
The Link Between Inflammaging and Degenerative Joint Diseases
Rezuş, E., Cardoneanu, A., Burlui, A., Luca, A., Codreanu, C., Tamba, B.-I., Stanciu, G. D., Dima, N., Badescu, C. M., & Rezuș, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030614 · Cited by 129
“The increased expression of p16 INK4a then activates pRB tumor suppressor, a mechanism by which cell proliferation is regulated through the formation of senescent-associated heterochromatin foci [102].”
BackgroundRoles and mechanisms of cellular senescence in regulation of tissue homeostasis
Ohtani, N., & Hara, E. (2013) · Cancer Science · doi:10.1111/cas.12118 · Cited by 119
The role of cold‐inducible RNA binding protein in cell stress response
Liao, Y., Tong, L., Tang, L., & Wu, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30833 · Cited by 131
“Senescent cells are characterized by certain distinctions, such as permanent growth arrest, increasing in cells size, positivity for bgalactosidase, secretion of a variety of inflammatory cytokines and expression of tumor suppressor p16INK4a.(89) Given that senescent cells were detected in human tumors associated with…”
BackgroundRouault, C., Pellegrinelli, V., Schilch, R., Cotillard, A., Poitou, C., Tordjman, J., Sell, H., Clément, K., & Lacasa, D. (2013) · Endocrinology · doi:10.1210/en.2012-1415 · Cited by 119
Erratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.225 · Cited by 128
SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence
Johmura, Y., Sun, J. M., Kitagawa, K., Nakanishi, K., Kuno, T., Naiki‐Ito, A., Sawada, Y., Miyamoto, T., Okabe, A., Aburatani, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10574 · Cited by 125
Of Flies, Mice, and Men: Evolutionarily Conserved Tissue Damage Responses and Aging
Neves, J., Demaria, M., Campisi, J., & Jasper, H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.11.028 · Cited by 126
“At the same time, work in vertebrates has established a critical role for the same paracrine signals in senescent cell-mediated tissue degeneration and even cancer in the aging adult (Adams, 2009; Campisi, 2013; Rodier and Campisi, 2011).”
BackgroundSelf-citationMetabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization
McFadden, K., Hafez, A. Y., Kishton, R. J., Messinger, J. E., Nikitin, P. A., Rathmell, J. C., & Luftig, M. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517141113 · Cited by 125
“Oncogene-induced senescence (OIS) is a premature form of senescence in which cells undergo an irreversible growth arrest after chronic oncogene expression or the inactivation of tumor suppressors (7, 8).”
BackgroundFang, Y., DeMarco, V. G., & Nicholl, M. B. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02272.x · Cited by 121
Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
Ding, Y., Zhou, Y., Ling, P., Feng, X., Luo, S., Zheng, X., Little, P. J., Xu, S., & Weng, J. (2021) · Theranostics · doi:10.7150/thno.64706 · Cited by 127
“Endothelial cell senescence is characterized by cell cycle arrest and pro-inflammatory gene expression [219-221] and is driven by many factors, including high glucose, ROS, inflammatory cytokines, ionizing radiation, and telomere dysfunction [222, 223].”
BackgroundParamos-de-Carvalho, D., Jacinto, A., & Saúde, L. (2021) · eLife · doi:10.7554/elife.72449 · Cited by 111
“Secretion of IL6 and IL- 8 has been shown to promote both tumourigenesis and tumour suppression in different contexts (Rodier and Campisi, 2011).”
BackgroundDellago, H., Preschitz‐Kammerhofer, B., Terlecki‐Zaniewicz, L., Schreiner, C., Fortschegger, K., Chang, M. W. ‐., Hackl, M., Monteforte, R., Kühnel, H., Schosserer, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12069 · Cited by 117
Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor
Neault, M., Mallette, F. A., Vogel, G., Michaud‐Levesque, J., & Richard, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks764 · Cited by 140
“Senescence is triggered by different cellular stresses, such as DNA damage, oxidative stress, telomere shortening and activated oncogenes (23,24).”
BackgroundJin, H. J., Lee, H. J., Heo, J., Lim, J., Kim, M., Kim, M. K., Nam, H. Y., Hong, G. H., Cho, Y. S., Choi, S. J., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6359 · Cited by 126
“Autocrine/paracrine-positive loop of MCP-1 secretion through CCR2 Cellular senescence can be stably sustained by the auto-crine/paracrine-positive regulatory loop of secreted SASP factors (28, 43).”
The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts
Kojima, H., Kunimoto, H., Inoue, T., & Nakajima, K. (2012) · Cell Cycle · doi:10.4161/cc.11.4.19172 · Cited by 128
“The SASP includes IL-1α, IL-1β, IL-6, CXCL8 and receptors for those cytokines.(2,7,26) Then we chose four factors, IL-1α, IL-1β, IL-6 and CXCL8/IL-8, and measured the mRNA levels for them in control TIG3 cells and TIG3 cells expressing HA-STAT3F using quantitative real-time PCR.”
BackgroundMethodNoncoding RNA in age-related cardiovascular diseases
Greco, S., Gorospe, M., & Martelli, F. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.011 · Cited by 120
“Secretion of some SASP factors (e.g., IL-6, IL-8) is under control of IRAK1, a protein whose levels are reduced by the senescence-associated miR-146.”
BackgroundInfluentialOncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 129
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic
Galiana, I., Lozano-Torres, B., Sancho, M., Alfonso, M., Bernardos, A., Bisbal, V., Serrano, M., Martínez-Máñez, R., & Orzáez, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.045 · Cited by 115
Thapa, R. K., Nguyen, H. T., Jeong, J.-H., Kim, J. R., Choi, H.-G., Yong, C. S., & Kim, J. O. (2017) · Scientific Reports · doi:10.1038/srep43299 · Cited by 115
DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
Malaquin, N., Carrier-Leclerc, A., Dessureault, M., & Rodier, F. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00094 · Cited by 136
“However, the SASP also generates chronic inflammation in normal tissues with persistent senescent cells, contributing to age-related tissue dysfunction (Rodier and Campisi, 2011).”
BackgroundInfluentialSelf-citationZito, E., Hansen, H. G., Yeo, G. S. H., Fujii, J., & Ron, D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.010 · Cited by 122
“The elevated TGF-b signature, with an attendant increase in IL-6 and P38 MAPK activity, nicely explains the growth-inhibited (Assoian and Sporn, 1986) and senescent phenotype (Rodier and Campisi, 2011) of the mutant cells.”
BackgroundSystemic induction of senescence in young mice after single heterochronic blood exchange
Jeon, O. H., Mehdipour, M., Gil, T.-H., Kang, M., Aguirre, N. W., Robinson, Z. R., Kato, C., Etienne, J., Lee, H. G., Alimirah, F., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00609-6 · Cited by 114
Self-citationByun, H.-O., Lee, Y.-K., Kim, J.-M., & Yoon, G. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.10.122 · Cited by 115
“fibronectin (51), PAI (52), and several SASP components (53, 54).”
BackgroundThe Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 136
“Moreover, SASP remodel tissue structure, disrupt local tissue integrity, and support tumor cell invasion and metastasis (Rodier and Campisi, 2011; Lecot et al., 2016).”
BackgroundAge-Induced Changes in White, Brite, and Brown Adipose Depots: A Mini-Review
Schosserer, M., Grillari, J., Wolfrum, C., & Scheideler, M. (2017) · Gerontology · doi:10.1159/000485183 · Cited by 135
Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity
Wang, B., Varela‐Eirin, M., Brandenburg, S. M., Hernandez‐Segura, A., van Vliet, T., Jongbloed, E. M., Wilting, S. M., Ohtani, N., Jager, A., & Demaria, M. (2022) · The EMBO Journal · doi:10.15252/embj.2021108946 · Cited by 113
“…chemo-and radiotherapy, cause high level of DNA damage in quickly proliferating cells and often achieve tumor suppression by leading cells into senescence — a stable form of growth arrest dependent on the upregulation of cyclin-dependent kinase (CDK) inhibitors p16 and p21 (Rodier & Campisi, 2011).”
Current Perspective in the Discovery of Anti-aging Agents from Natural Products
Ding, A., Zheng, S., Huang, X., Xing, T.-K., Wu, G.-S., Sun, H., Qi, S., & Luo, H. (2017) · Natural Products and Bioprospecting · doi:10.1007/s13659-017-0135-9 · Cited by 125
Lewińska, A., Adamczyk‐Grochala, J., Błoniarz, D., Olszowka, J., Kulpa-Greszta, M., Litwinienko, G., Tomaszewska, A., Wnuk, M., & Pązik, R. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101337 · Cited by 117
“, by the induction of tumorigenesis [1].”
Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study
Blitzer, A. L., Ham, S. A., Colby, K. A., & Skondra, D. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.6331 · Cited by 123
Aneuploidy in health, disease, and aging
Ricke, R. M., & van Deursen, J. M. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201301061 · Cited by 124
“Another example is BubR1 hypomorphism, which besides aneuploidy promotes senescence, a widely recognized anticancer mechanism (Baker et al., 2008; Rodier and Campisi, 2011).”
3′ UTR lengthening as a novel mechanism in regulating cellular senescence.
Chen, M., Lyu, G., Han, M., Nie, H., Shen, T., Chen, W., Niu, Y., Song, Y., Li, X., Li, H., et al. (2018) · Genome Research · doi:10.1101/gr.224451.117 · Cited by 111
“In addition to telomere erosion, many stimuli and stresses can cause cellular senescence, including DNA double-strand breaks, strong mitogenic signals, oxidative stress, and ectopic expression of cyclin-dependent kinase inhibitors (CDKIs) (Xue et al. 2004; Rodier and Campisi 2011; Li et al. 2013).”
BackgroundTelomeres, Telomerase and Ageing
Saretzki, G. (2018) · Subcellular Biochemistry · doi:10.1007/978-981-13-2835-0_9 · Cited by 93
Avvakumov, N., Lalonde, M., Saksouk, N., Paquet, É. R., Glass, K. C., Landry, A.-J., Doyon, Y., Cayrou, C., Robitaille, G., Richard, D. E., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06455-11 · Cited by 121
“Interaction of ING5 with domain IIb of JADE1 was specifically required for this stimulation, as JADE1(1-600),”
BackgroundInfluentialExpansion and Cell-Cycle Arrest: Common Denominators of Cellular Senescence
Ogrodnik, M., Salmonowicz, H., Jurk, D., & Passos, J. F. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.06.011 · Cited by 104
Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
Bojko, A., Czarnecka‐Herok, J., Charzyńska, A., Dąbrowski, M., & Sikora, E. (2019) · Cells · doi:10.3390/cells8121501 · Cited by 121
“SASP production during senescence could be explained by a classic pathway, namely, induction of DNA damage upon drug treatment, followed by upregulation and activation of ATM.”
BackgroundInfluentialAccelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity
Mitry, M. A., Laurent, D., Keith, B. L., Sira, E., Eisenberg, C. A., Eisenberg, L. M., Joshi, S. R., Gupte, S. A., & Edwards, J. G. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00073.2019 · Cited by 114
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases
Balasubramanian, P., Hall, D., & Subramanian, M. (2018) · GeroScience · doi:10.1007/s11357-018-0048-5 · Cited by 116
LncRNAs Regulatory Networks in Cellular Senescence
Pavan Kumar, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112615 · Cited by 113
“Cytokine-induced feedback loops are classical examples of positive feedback mechanisms reported for SASP-mediated paracrine regulation of senescence [61].”
BackgroundMechanistic links between aging and lung fibrosis
Thannickal, V. J. (2013) · Biogerontology · doi:10.1007/s10522-013-9451-6 · Cited by 107
“Thus, similar to its role in tumor-suppression, cellular senescence may function as a mechanism for fibrosissuppression (Rodier and Campisi 2011).”
Implications of time-series gene expression profiles of replicative senescence.
Kim, Y., Byun, H., Jee, B. A., Cho, H., Seo, Y., Kim, Y., Park, M. H., Chung, H., Woo, H. G., & Yoon, G. (2013) · Aging Cell · doi:10.1111/acel.12087 · Cited by 106
HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction
Rajagopalan, S. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.53 · Cited by 106
Evidence and perspectives of cell senescence in neurodegenerative diseases
Si, Z., Sun, L., & Wang, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111327 · Cited by 105
Gopinath, P. M., Twayana, K. S., Ravanan, P., Thomas, J., Mukherjee, A., Jenkins, D., & Chandrasekaran, N. (2021) · Particle and Fibre Toxicology · doi:10.1186/s12989-021-00428-9 · Cited by 117
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.